Clinical Trial Update: Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis [Phase 2]

View source ↗

Summary

Urigen's Phase 2 study of URG101 for painful bladder syndrome and interstitial cystitis was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• URG101

Snippet

Sponsor: Urigen | Conditions: Painful Bladder Syndrome, Interstitial Cystitis | Phase 2 | Status: TERMINATED | Results posted: 2024-08-23